Susquehanna Fundamental Investments’s Orphazyme A/S ORPH Stock Holding History

Susquehanna Fundamental Investments’s Portfolio ORPH Stock Details ORPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-75,758	Closed	-$183K	–	1744
2021 Q4	$183K	Sell	75,758 -10,423	-12%	-$36.8K	﹤0.01%	1269
2021 Q3	$354K	Buy	+86,181	New	+$443K	0.01%	1348

Other funds holding ORPH

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Susquehanna Fundamental Investments's ORPH Position: Q1 2022 in Review

Susquehanna Fundamental Investments sold out of Orphazyme A/S (ORPH) in Q1 2022, closing a stake of 75,758 shares — an estimated $183K sold.

Susquehanna Fundamental Investments first reported a position in ORPH in Q3 2021 and held it in 2 quarters. The position peaked at $354K in Q3 2021. 4 funds tracked by Wall St. Rank hold ORPH as of Q1 2022.

Susquehanna Fundamental Investments reported no remaining Orphazyme A/S position as of Q1 2022 after selling out during the quarter.
Susquehanna Fundamental Investments sold 75,758 Orphazyme A/S shares in Q1 2022, an estimated $183K.
Susquehanna Fundamental Investments first reported a position in Orphazyme A/S in Q3 2021 and held it in 2 quarters.
Susquehanna Fundamental Investments's Orphazyme A/S position peaked at $354K in Q3 2021.
4 funds tracked by Wall St. Rank held Orphazyme A/S as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.